Aiming to cure HER2-positive early breast cancer


This new triple combination treatment aims to wipe out any remaining breast cancer cells after surgery to remove the tumour in early breast cancer, with the aim to cure. — AFP

Breast cancer is the most common cancer among women globally. Every 15 seconds, one woman is diagnosed with breast cancer somewhere in the world.

It is the most common form of malignancy affecting women. In Malaysia, breast cancer affects 32.1% of all female cancer patients.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Others Also Read